EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Updating Primary Antibiotic Resistance in Helicobacter pylori Strains Isolated in Italy

Ilaria Maria Saracino, Matteo Pavoni, Giulia Fiorini, Angelo Zullo, Andrea Imbrogno, Tiziana Lazzarotto, Claudio Borghi, Dino Vaira

Journal of Gastrointestinal and Liver Diseases · 28.12.2024 · 33 (4) · 463-467

DOI: 10.15403/jgld-5617 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastrointestinal and Liver Diseases, online erschienen am 28.12.2024. Verfasst von Ilaria Maria Saracino und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences, IRCCS St. Orsola Polyclinic, University of Bologna, Bologna, Italy. . ilariamaria.saracino@studio.unibo.…. Hauptthemen laut MEDLINE: Helicobacter pylori, Helicobacter Infections, Anti-Bacterial Agents, Microbial Sensitivity Tests. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims: Bacterial resistance toward the most used antibiotics is increasing in Helicobacter pylori (H. pylori) strains worldwide. The emergence of multidrug resistance significantly affects the efficacy of standard therapy regimens. Therefore, this prospective study has updated the prevalence rates of primary antibiotic resistance in H. pylori strains isolated in routine practice.

Methods

H. pylori isolates obtained from patients consecutively observed in a single center were tested for primary resistance by using the E-test method. The minimum inhibitory concentration (MIC) breakpoints to define resistance to clarithromycin, metronidazole, and levofloxacin were, respectively, greater than 0. 25 mg/L, 8 mg/L, and 1 mg/L, according to updated EUCAST recommendations. The trend of antibiotic prevalence, either single or combined, during 2020–2023 was assessed.

Results

A total of 789 patients meeting inclusion criteria were diagnosed with H. pylori infection, but bacterial strains were overall recovered in 632 (80.1%) cases. At bacterial culture, primary resistance rate was 36.7% for clarithromycin, 32.8% for metronidazole, and 22.1% for levofloxacin, whilst dual clarithromycin-metronidazole resistance rate was detected in 17.4%, and triple resistance in 9%.

Conclusions

Our data found that primary resistance towards both clarithromycin and metronidazole, as well as dual resistance, is substantially stable in Italy whilst the prevalence of levofloxacin resistance seems to be decreasing in our geographic area.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter pyloriHelicobacter InfectionsAnti-Bacterial AgentsMicrobial Sensitivity TestsMetronidazoleClarithromycinLevofloxacinDrug Resistance, Multiple, BacterialHumansItalyMaleFemaleProspective StudiesMiddle AgedAdultAgedPrevalenceDrug Resistance, Bacterial

Substanzen

Anti-Bacterial AgentsMetronidazoleClarithromycinLevofloxacin

Autor:innen und Institutionen

  • Department of Medical and Surgical Sciences, IRCCS St. Orsola Polyclinic, University of Bologna, Bologna, Italy. . ilariamaria.saracino@studio.unibo.it.
  • Department of Medical and Surgical Sciences, IRCCS St. Orsola Polyclinic, University of Bologna, Bologna, Italy. matteo.pavoni2@unibo.it.
  • Department of Cardiovascular Medicine Unit, Heart, Chest and Vascular, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. giulia.fiorini@aosp.bo.it.
  • Gastroenterology and Digestive Endoscopy, Nuovo Regina Margherita Hospital, Rome, Italy. zullo66@gmail.com.
  • Emergency room and territorial emergency Spoke Area, Bologna, Italy. imbrognoandrea@gmail.com.
  • Department of Medical and Surgical Sciences, IRCCS St. Orsola Polyclinic, University of Bologna, Bologna; Microbiology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. tiziana.lazzarotto@unibo.i…

Zitieren

APA

Saracino, I. M., Pavoni, M., Fiorini, G., Zullo, A., Imbrogno, A., Lazzarotto, T., Borghi, C., & Vaira, D. (2024). Updating Primary Antibiotic Resistance in Helicobacter pylori Strains Isolated in Italy. Journal of Gastrointestinal and Liver Diseases, 33(4), 463-467. https://doi.org/10.15403/jgld-5617

Vancouver

Saracino IM, Pavoni M, Fiorini G, Zullo A, Imbrogno A, Lazzarotto T, et al. Updating Primary Antibiotic Resistance in Helicobacter pylori Strains Isolated in Italy. Journal of Gastrointestinal and Liver Diseases. 2024;33(4):463-467. doi:10.15403/jgld-5617

BibTeX
@article{Saracino2024,
  author = {Saracino, Ilaria Maria and Pavoni, Matteo and Fiorini, Giulia and Zullo, Angelo and Imbrogno, Andrea and Lazzarotto, Tiziana and Borghi, Claudio and Vaira, Dino},
  title = {Updating Primary Antibiotic Resistance in Helicobacter pylori Strains Isolated in Italy},
  journal = {Journal of Gastrointestinal and Liver Diseases},
  year = {2024},
  volume = {33},
  number = {4},
  pages = {463--467},
  doi = {10.15403/jgld-5617}
}
Kostenlos starten →